TLN-121 in Relapsed or Refractory Non-Hodgkin Lymphomas

NCT07082803 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

180

Enrollment

INDUSTRY

Sponsor class

Conditions

Lymphoma
Lymphoma, Non Hodgkin

Interventions

DRUG: TLN-121
DRUG: TLN-254
DRUG: TLN-121

Sponsor

Treeline Biosciences, Inc.